Anti-CEBP alpha/CEBPA Antibody, Rabbit Polyclonal sinobiological 100364-T08

$243.00
In stock
SKU
100364-T08
Catalog No.SizePrice (USD)
100364-T08-100100 µL$251.64

General Information

Product nameAnti-CEBP alpha/CEBPA Antibody, Rabbit Polyclonal
Validated applicationsIHC-P (FAQ Protocol)
Species reactivityReacts with: Human
SpecificityHuman Mouse, Rat (Species predicted to react based on 100% sequence homology)
ImmunogenA synthetic peptide corresponding to the C-terminus of the Human CEBP alpha/CEBPA
PreparationProduced in rabbits immunized with a synthetic peptide corresponding to the C-terminus of the Human CEBP alpha/CEBPA, and purified by antigen affinity chromatography.
SourcePolyclonal Rabbit IgG
PurificationProtein A & Antigen Affinity
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Synonyms: Anti-C/EBP-alpha Antibody; Anti-CEBP Antibody

Image / Experimental Information

Image 1 DescriptionImmunochemical staining of human CEBPA in human lung with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.
Image 1 Alt TextHuman CEBP alpha/CEBPA Immunohistochemistry(IHC) 36332
Image 1 URLSource image
Image 2 DescriptionImmunochemical staining of human CEBPA in human lung with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.
Image 2 Alt TextHuman CEBP alpha/CEBPA Immunohistochemistry(IHC) 36333
Image 2 URLSource image

Background Information

Full NameCCAAT/enhancer binding protein alpha
DescriptionThe CCAAT/enhancer-binding protein-alpha (CEBPA) is a lineage-specific transcription factor in the hematopoietic system. The presence of biallelic CEBPA mutations is a favourable prognostic feature in acute myeloid leukaemia (AML). CEBPA mutations are currently identified through conventional capillary sequencing (CCS). Mutations in CCAAT/enhancer binding protein alpha (CEBPA) occur in 5-10% of cases of acute myeloid leukemia. CCAAT/enhancer binding protein alpha gene (CEBPA) is an important transcription factor in maintenance of differentiation of granulocyte series of hematopoietic system. It plays a key role in regulating cell proliferation and differentiation.
Related Pathways
  • IL17 signaling pathway

Reviews

Write Your Own Review
You're reviewing:Anti-CEBP alpha/CEBPA Antibody, Rabbit Polyclonal sinobiological 100364-T08
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.